In a report released today, Joseph France from Cantor Fitzgerald maintained a Buy rating on AAC Holdings (AAC), with a price target of $14. The company’s shares closed yesterday at $5.31, close to its 52-week low of $4.91.
France noted:
“We rate AAC $14 price target. AAC is the only freestanding, publicly traded provider that is focused entirely on the treatment of substance abuse, a large, chronic market that is underserved, highly fragmented and best managed, in our view, with an evidence-based treatment model that addresses both the addiction and the related medical problems that afflict nearly half of drug abusers.”
According to TipRanks.com, France is a 5-star analyst with an average return of 10.4% and a 59.4% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and Addus Homecare Corp.
AAC Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $13.
See today’s analyst top recommended stocks >>
Based on AAC Holdings’ latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $3.01 million. In comparison, last year the company had a net profit of $762K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AAC Holdings, Inc. engages in the provision of rehabilitation operation. It operates through Substance Abuse and Behavioral Healthcare Treatment Services segment that consists of various treatment facilities in the United States. It offers inpatient and outpatient substance abuse treatment services to individual with drugs and alcohol addiction.
